310 related articles for article (PubMed ID: 34498147)
1. Solvent-Assisted Hot Melt Extrusion of a Thermally Labile, High Melting Point Compound.
Lagan C; Huckle JE; Katz JM; Khorsand B; Daurio D; Andrews GP; Chung J; Alvarez-Nunez F
AAPS PharmSciTech; 2021 Sep; 22(7):235. PubMed ID: 34498147
[TBL] [Abstract][Full Text] [Related]
2. The application of temperature-composition phase diagrams for hot melt extrusion processing of amorphous solid dispersions to prevent residual crystallinity.
Moseson DE; Taylor LS
Int J Pharm; 2018 Dec; 553(1-2):454-466. PubMed ID: 30393199
[TBL] [Abstract][Full Text] [Related]
3. Rheology Guided Rational Selection of Processing Temperature To Prepare Copovidone-Nifedipine Amorphous Solid Dispersions via Hot Melt Extrusion (HME).
Yang F; Su Y; Zhang J; DiNunzio J; Leone A; Huang C; Brown CD
Mol Pharm; 2016 Oct; 13(10):3494-3505. PubMed ID: 27602878
[TBL] [Abstract][Full Text] [Related]
4. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
[TBL] [Abstract][Full Text] [Related]
5. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
6. An innovative carrier for the formulation of amorphous solid dispersion by hot-melt extrusion with no further downstream processes: a case study with indomethacin.
Lacerda SP; Del Confetto S; Haurie L; Bernard M; Faget S; Ré MI
Pharm Dev Technol; 2024 Feb; 29(2):131-142. PubMed ID: 38235570
[TBL] [Abstract][Full Text] [Related]
7. Holistic QbD approach for hot-melt extrusion process design space evaluation: Linking materials science, experimentation and process modeling.
Evans RC; Bochmann ES; Kyeremateng SO; Gryczke A; Wagner KG
Eur J Pharm Biopharm; 2019 Aug; 141():149-160. PubMed ID: 31132400
[TBL] [Abstract][Full Text] [Related]
8. Hot Melt Extrusion as Solvent-Free Technique for a Continuous Manufacturing of Drug-Loaded Mesoporous Silica.
Genina N; Hadi B; Löbmann K
J Pharm Sci; 2018 Jan; 107(1):149-155. PubMed ID: 28603020
[TBL] [Abstract][Full Text] [Related]
9. Processing thermally labile drugs by hot-melt extrusion: The lesson with gliclazide.
Huang S; O'Donnell KP; Delpon de Vaux SM; O'Brien J; Stutzman J; Williams RO
Eur J Pharm Biopharm; 2017 Oct; 119():56-67. PubMed ID: 28583588
[TBL] [Abstract][Full Text] [Related]
10. A Hot-Melt Extrusion Risk Assessment Classification System for Amorphous Solid Dispersion Formulation Development.
Kyeremateng SO; Voges K; Dohrn S; Sobich E; Lander U; Weber S; Gessner D; Evans RC; Degenhardt M
Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631630
[TBL] [Abstract][Full Text] [Related]
11. Vacuum drum drying - A novel solvent-evaporation based technology to manufacture amorphous solid dispersions in comparison to spray drying and hot melt extrusion.
Schönfeld B; Westedt U; Wagner KG
Int J Pharm; 2021 Mar; 596():120233. PubMed ID: 33484914
[TBL] [Abstract][Full Text] [Related]
12. Impact of Hot-Melt Extrusion Processing Conditions on Physicochemical Properties of Amorphous Solid Dispersions Containing Thermally Labile Acrylic Copolymer.
Mathers A; Hassouna F; Malinová L; Merna J; Růžička K; Fulem M
J Pharm Sci; 2020 Feb; 109(2):1008-1019. PubMed ID: 31605688
[TBL] [Abstract][Full Text] [Related]
13. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
14. An approach for chemical stability during melt extrusion of a drug substance with a high melting point.
Haser A; Huang S; Listro T; White D; Zhang F
Int J Pharm; 2017 May; 524(1-2):55-64. PubMed ID: 28359810
[TBL] [Abstract][Full Text] [Related]
15. Process analytical techniques for hot-melt extrusion and their application to amorphous solid dispersions.
Hitzer P; Bäuerle T; Drieschner T; Ostertag E; Paulsen K; van Lishaut H; Lorenz G; Rebner K
Anal Bioanal Chem; 2017 Jul; 409(18):4321-4333. PubMed ID: 28343348
[TBL] [Abstract][Full Text] [Related]
16. The role of the polymer matrix in solvent-free hot melt extrusion continuous process for mechanochemical synthesis of pharmaceutical cocrystal.
Gajda M; Nartowski KP; Pluta J; Karolewicz B
Eur J Pharm Biopharm; 2018 Oct; 131():48-59. PubMed ID: 30205892
[TBL] [Abstract][Full Text] [Related]
17. A systematic and robust assessment of hot-melt extrusion-based amorphous solid dispersions: Theoretical prediction to practical implementation.
Alzahrani A; Nyavanandi D; Mandati P; Youssef AAA; Narala S; Bandari S; Repka M
Int J Pharm; 2022 Aug; 624():121951. PubMed ID: 35753536
[TBL] [Abstract][Full Text] [Related]
18. An investigation into the influence of drug-polymer interactions on the miscibility, processability and structure of polyvinylpyrrolidone-based hot melt extrusion formulations.
Chan SY; Qi S; Craig DQ
Int J Pharm; 2015 Dec; 496(1):95-106. PubMed ID: 26428633
[TBL] [Abstract][Full Text] [Related]
19. Downstream processing from hot-melt extrusion towards tablets: A quality by design approach.
Grymonpré W; Bostijn N; Herck SV; Verstraete G; Vanhoorne V; Nuhn L; Rombouts P; Beer T; Remon JP; Vervaet C
Int J Pharm; 2017 Oct; 531(1):235-245. PubMed ID: 28823887
[TBL] [Abstract][Full Text] [Related]
20. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
